4th Neuroimmunology Drug Development Summit
Evvnt Promotion / evvnt
18.04.2022 - 20.04.2022 Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, USA
Time: 08:30 - 16:10
Temas de la conferencia
Since 2019, venture capitalists have been predicting a "golden era of neuroscience products" and successes of "radical new breakthrough therapies" in the notoriously challenging space.
Now, three years on, 2022 is hosting the neuroscience renaissance and pharma is doubling down to understand the neuropathological and neuroprotective role of neuroinflammation as the most promising opportunity to bring more targeted, precise and transformative therapies
Since 2019, venture capitalists have been predicting a "golden era of neuroscience products" and successes of "radical new breakthrough therapies" in the notoriously challenging space.
Now, three years on, 2022 is hosting the neuroscience renaissance and pharma is doubling down to understand the neuropathological and neuroprotective role of neuroinflammation as the most promising opportunity to bring more targeted, precise and transformative therapies
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/956949-3?pid=4832
Speakers: Alejandro Rangel, Applied Neurosciences Department Head, Mexican Council of Neuroscience, Andrea Crotti, Principal Scientist, Takeda Pharmaceutical and more.
Brochure: https://go.evvnt.com/956949-3?pid=4832
Speakers: Alejandro Rangel, Applied Neurosciences Department Head, Mexican Council of Neuroscience, Andrea Crotti, Principal Scientist, Takeda Pharmaceutical and more.
Información e inscripción:
https://go.evvnt.com/956949-2?pid=4832
Ms. Stephanie Nketia
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
